System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Menno V Huisman is an expert in Hematology at Leiden University Medical Center (Netherlands). As of October 2026, ScienceLeadR ranks Menno V Huisman in the top 1% of experts worldwide for Pulmonary Embolism, Embolism and Thrombosis and Atrial Fibrillation. Menno V Huisman has authored 732 publications, the most recent in 2026, and is an investigator in 23 clinical trials, 3 of them ongoing. SLR score: 2,605 (community average: 125). How the SLR is computed.

LeadR Profile

Menno V Huisman Leiden University Medical Center Netherlands
2 605 ScienceLeadR Reputation 2605

Unlock

Register Login
Network Map

Hematology

Subspecialties: Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026
Source: PubMed

Leiden University Medical Center

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 732

Citations

Citations: 57 412 1st author: 41 Last author: 180 Unique author: 20

Main journals

J Thromb Haemost 83
Thromb Res 66
Thromb Haemost 44
Eur Heart J 37
Blood 27

Best Journals

N Engl J Med 11
Eur Heart J 10
JAMA 6

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
DUTCH weight control in atrial fibrillation study (DUTCH-WAIST) : Design and rationale of a randomised controlled trial.
PMID 42734721 — life style, electric countershock, atrial fibrillation, overweight, weight control, semaglutide		Neth Heart J20260
Development and External Validation of the GLORIA-AF Bleeding Weighted Risk Score for Patients with Atrial Fibrillation.
PMID 42667266 — registries, hemorrhage, cardiovascular diseases, atrial fibrillation		Eur J Prev Cardiol20260
Development and Validation of the GLORIA-AF Stroke Weighted Risk Score for Patients with Atrial Fibrillation.
PMID 42667264 — stroke, atrial fibrillation		Europace20260
Elevated on-treatment D-dimer level is associated with major bleeding during extended anticoagulation for venous thromboembolism.
PMID 42459131 — anticoagulants, thromboembolism, hemorrhage, incidence, intracranial hemorrhages, therapeutics, venous thromboembolism		Haematologica20260
Prognosis Prediction and Shared Decision Making for Personalised Anticoagulant Therapy after Unprovoked Venous Thromboembolism: The MORPHEUS project.
PMID 42447897 — anticoagulants, thromboembolism, hemorrhage, decision making, shared, decision making, biomarkers, therapeutics, venous thromboembolism, thrombosis, prognosis, hemostasis		Thromb Haemost20260

Clinical Studies 23

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 11
Phase 4 6
Phase 3 5
Phase 2/Phase 3 1

By status:

Completed 16
Active not recruiting 3
Recruiting 2
Terminated 2

By type:

Interventional 19
Observational 4

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 3
multicentricup10 16

Main Topics

Cohort/Consortium Investigators 3

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
inDividual Targeted thrombosIS Prophylaxis Versus the Standard One Size Fits All Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT06581965 — arthroplasty, anticoagulants, thromboembolism, embolism, surgical wound, hemorrhage, hospitalization, rivaroxaban, venous thrombosis, multiple chronic conditions, kidney, pulmonary embolism, precision medicine, therapeutics, venous thromboembolism, thrombosis, blood platelets, heparin, low-molecular-weight, arthroplasty, replacement, knee, veins, dabigatran, direct-acting oral anticoagulants, apixaban		Phase 4Recruiting2024
Leiden Thrombosis Recurrence Risk Prevention
NCT06087952 — anticoagulants, thromboembolism, embolism, hemorrhage, venous thrombosis, pulmonary embolism, therapeutics, venous thromboembolism, thrombosis, veins		N/AActive not recruiting2021
Pulmonary Embolism International THrOmbolysis Study 3
NCT04430569 — embolism, plasminogen, plasminogen activators, tissue plasminogen activator, pulmonary embolism, therapeutics, tissues, infusions, intravenous		Phase 3Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS